Showing results (291-300 of 317) with videos related to

Sort By:
Pageof 32
Archives of Pathology & Laboratory Medicine|August 21, 2019
Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431Kelley J Mast, Jeffrey W Taub, Todd A Alonzo, et al.
European Heart Journal Open|August 29, 2023
Cardiovascular outcomes in patients with coronary artery disease and elevated lipoprotein(a): implications for the OCEAN(a)-outcomes trial populationArthur Shiyovich, Adam N Berman, Stephanie A Besser, et al.
Cancer Research Communications|July 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision TherapyNadine Azzam, Jamie I Fletcher, Nicole Melong, et al.
European Heart Journal|October 13, 2020
Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registryErsilia M DeFilippis, Bradley L Collins, Avinainder Singh, et al.
Blood|April 9, 2017
Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trialJeffrey W Taub, Jason N Berman, Johann K Hitzler, et al.
European Journal of Preventive Cardiology|September 19, 2025
Association between lipoprotein(a) and cardiovascular events in patients with peripheral artery disease: the Mass General Brigham Lp(a) registryDaniel J McClintick, David W Biery, Adam N Berman, et al.
JACC. Cardiovascular Imaging|October 28, 2025
Prevalence and Prognostic Value of Incidentally Detected Coronary Artery Calcium Using Artificial Intelligence Among Individuals With Immune-Mediated Inflammatory DiseasesBrittany N Weber, David W Biery, Milena Petranovic, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 3, 2023
Tissue-Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC InhibitionAdam Pietrobon, Julien Yockell-Lelièvre, Nicole Melong, et al.
Blood|July 28, 2021
High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trialJohann Hitzler, Todd Alonzo, Robert Gerbing, et al.
JAMA Cardiology|May 19, 2021
Association of Socioeconomic Disadvantage With Long-term Mortality After Myocardial Infarction: The Mass General Brigham YOUNG-MI RegistryAdam N Berman, David W Biery, Curtis Ginder, et al.
Pageof 32